Observational study on the use of B cell receptor kinase inhibitors and BCL2 antagonists prior to allogeneic hematopoietic stem cell transplantation for B cell malignancies: A joint project of the EBMT Lymphoma and Chronic Malignancy Working Parties. Type of transplant Principal investigator Peter Dreger, Johannes Schetelig
RICMAC: Dose-reduced versus standard conditioning followed by allogeneic stem cell transplantation in patients with MDS or sAML: A randomised phase III study Type of transplant Principal investigator Nicolaus Kröger
MMVAR: A Randomised Controlled study of Velcade (Bortezomib) plus Thalidomide plus Dexamethasone compared to Thalidomide plus Dexamethasone for the treatment of myeloma patients progressing or relapsing after autologous transplantation Type of transplant Principal investigator Laurent Garderet
High dose immunoablation and autologous hematopoietic stem cell transplantation versus monthly intravenous pulse therapy cyclophosphamide in severe systemic sclerosis Type of transplant Principal investigator J.M. van Laar
Autologous Stem Cell Transplantation International Crohn's Disease Trial: a multicentre, prospective, randomised phase II study conducted by the European Crohn's and Colitis Organisation (ECCO), sponsored by the Autoimmune Diseases Working Party of the European Society for Blood and Marrow Transplantation Type of transplant Principal investigator Christopher J Hawkey
Elderly AML: A randomised Phase III study comparing conventional chemotherapy to low dose total body irradiation-based conditioning and hematopoietic stem cell transplantation from related and unrelated donors as consolidation therapy for older patients with AML in 1st complete remission Type of transplant Principal investigator Dietger Niederwieser
Non-interventional prospective study on HHV-6 disease and HHV-6 chromosomal integration Type of transplant Principal investigator Kate Ward